New York Life Investment Management LLC Acquires 108 Shares of Waters Co. (NYSE:WAT)

New York Life Investment Management LLC raised its holdings in Waters Co. (NYSE:WAT) by 1.2% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 8,910 shares of the medical instruments supplier’s stock after acquiring an additional 108 shares during the quarter. New York Life Investment Management LLC’s holdings in Waters were worth $3,305,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in WAT. International Assets Investment Management LLC grew its position in shares of Waters by 52,500.0% during the 3rd quarter. International Assets Investment Management LLC now owns 6,838 shares of the medical instruments supplier’s stock worth $2,461,000 after buying an additional 6,825 shares in the last quarter. Cigna Investments Inc. New bought a new position in shares of Waters during the 3rd quarter worth $217,000. Eads & Heald Wealth Management grew its position in shares of Waters by 31.4% during the 3rd quarter. Eads & Heald Wealth Management now owns 1,240 shares of the medical instruments supplier’s stock worth $446,000 after buying an additional 296 shares in the last quarter. Farther Finance Advisors LLC grew its position in shares of Waters by 6.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,204 shares of the medical instruments supplier’s stock worth $433,000 after buying an additional 78 shares in the last quarter. Finally, Private Wealth Partners LLC bought a new position in shares of Waters during the 3rd quarter worth $288,000. Institutional investors own 94.01% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on the company. Sanford C. Bernstein raised Waters from a “market perform” rating to an “outperform” rating and set a $430.00 price target on the stock in a research report on Friday, January 10th. TD Cowen upped their price objective on Waters from $363.00 to $410.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. UBS Group upped their price objective on Waters from $405.00 to $410.00 and gave the stock a “neutral” rating in a research note on Thursday, February 13th. Barclays upgraded Waters from an “underweight” rating to an “equal weight” rating and upped their price objective for the stock from $360.00 to $415.00 in a research note on Monday, February 10th. Finally, Bank of America decreased their price objective on Waters from $430.00 to $410.00 and set a “neutral” rating for the company in a research note on Thursday, February 13th. Eleven research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $390.40.

Waters Trading Up 1.1 %

Waters stock opened at $377.22 on Friday. The stock has a 50-day moving average of $390.04 and a two-hundred day moving average of $367.50. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters Co. has a one year low of $279.24 and a one year high of $423.56. The stock has a market cap of $22.40 billion, a PE ratio of 35.22, a price-to-earnings-growth ratio of 3.79 and a beta of 1.01.

Waters (NYSE:WAT) last released its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating analysts’ consensus estimates of $4.02 by $0.08. Waters had a return on equity of 46.31% and a net margin of 21.56%. On average, research analysts anticipate that Waters Co. will post 12.86 EPS for the current fiscal year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.